Key result
Peak-free BCG signal screening boosts downstream model discrimination by ~0.14 AUC vs. unscreened data.
Why the study?
Ballistocardiogram signal quality assessment is critical for reliable cardiac monitoring and disease prediction, but existing methods rely on peak detection, which is unreliable for BCG due to its multi-lobed morphology.
Does a peak-free autocorrelation-based signal quality assessment method improve the identification of usable ballistocardiogram segments and downstream model performance compared to peak-based baselines and unscreened cohorts?
Does a peak-free autocorrelation-based signal quality assessment method improve the identification of usable ballistocardiogram segments and downstream model performance compared to peak-based baselines and unscreened cohorts?
A peak-free, windowed autocorrelation signal quality assessment method reliably screens ballistocardiogram recordings and substantially improves downstream deep learning model performance (AUC 0.815 vs 0.675).
Ballistocardiogram (BCG) signal quality assessment (SQA) is critical for reliable cardiac monitoring and disease prediction. Existing SQA methods for physiological signals typically rely on peak detection, which is unreliable for BCG due to its multi-lobed morphology. We propose a peak-free SQA method that evaluates signal periodicity through windowed autocorrelation, retains power spectral concentration only as an auxiliary descriptor, and aggregates the autocorrelation peaks by the median into a robust subject-level index. Evaluated on a 46-subject dataset with synchronized reference ECG, the method yields an interpretable quality stratification. Using the reference ECG as ground truth, the index is strongly predictive of BCG usefulness: high-quality windows achieve substantially lower heart-rate error and a much higher proportion of clinically usable segments compared to low-quality windows. In discriminating usable windows, the proposed index significantly outperforms peak-based and statistical SQI baselines. Furthermore, the screened 1D-ConvVAE pipeline achieved an AUC of 0.815 versus 0.675 for the full cohort. A same-model, within-cohort stratified evaluation showed higher AUC on good- than lower-quality subjects (0.765 vs.\ 0.587); a filter ablation indicates that bandpass filtering alone does not account for the observed difference. The method provides a reliable, peak-free SQA approach for BCG, enabling automatic quality screening for large-scale datasets.
No takes yet. Share an insight, caveat, or question.
Ren et al. (2026) studied Cardiac monitoring using ballistocardiogram (BCG) (n=46). Peak-free autocorrelation-based signal quality assessment (SQA) method vs. Peak-based and statistical signal quality index (SQI) baselines, and unscreened full cohort was evaluated on Downstream 1D-ConvVAE classification performance (AUC) and discrimination of usable BCG windows (AUC 0.815 vs 0.675). Peak-free autocorrelation-based BCG signal quality screening improved downstream 1D-ConvVAE model performance, achieving an AUC of 0.815 vs. 0.675 for the unscreened full cohort.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: